Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VC005 in Mild to Moderate Atopic Dermatitis
NCT06891040Phase 2Completed
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- Apr 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VC-005 in atopic dermatitis (AD), sponsored by Jiangsu Vcare PharmaTech Co., Ltd.. Started Apr 2025; status: completed.
02
Drugs
VC-005
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT06891040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06891040.